AMELUZ® - medicinal product

Ameluz® is Biofrontera’s first prescription drug. Further information is available on the webpage of the European Medicines Agency.



BF-RhodoLED® – medical device

BF-RhodoLED® is a lamp for photodynamic therapy (PDT) with LEDs emitting red light at an average wavelength of 635 nm. This wavelength is perfectly suited for the illumination in PDT with medicines containing ALA. BF-RhodoLED® has been CE-certified, which enables marketing throughout the entire EU.

BF-RhodoLED® is unique in that it has an adjustable fan and allows to modify the light intensity at a constant light dose. This renders the generally 10-minute PDT illumination most comfortable for the patient.



Xepi® - licensed product marketed in the US

Biofrontera holds the exclusive license to market and disributes the topical antibiotic Xepi® (ozenoxacin cream, 1%) in the USA. 



belixos® - cosmetic product

belixos® is a modern active cosmetic product specially developed for sensitive and irritated skin. Biofrontera's patented biocolloid technology, which optimizes epidermal penetration, makes the products unique: pure herbal biocolloids combine with medicinal plant extracts to form an extraordinary combination of active ingredients with a proven depth effect. The belixos® series includes the following products: belixos® Liquid and belixos® Protect.

Detailed information about our active cosmetic series can be found here.